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Since the inception of nuclear reprogramming, the parallels between this process and tumorigenesis have
become increasingly apparent. Recent studies by Abad et al. and Ohnishi et al. have now formalized this
connection by demonstrating that the same transcription factors used for reprogramming to pluripotency
drive tumor initiation in vivo.Although experimental conditions allow-
ing nuclear reprogramming in vitro have
been well established (Stadtfeld and Ho-
chedlinger, 2010), whether an in vivo envi-
ronment would also support induced
pluripotent stem cell (iPSC) formation
from adult somatic cells has remained
essentially unexplored. This open ques-
tion within the field is now addressed in
two new studies using doxycycline-
inducible reprogramming factors (Oct3/4,
Klf4, Sox2, and c-Myc; OKSM) in trans-
genic mice (Abad et al., 2013; Ohnishi
et al., 2014). They demonstrate that doxy-
cycline-inducible expression of OKSM in
adults can ultimately lead to formation of
teratomas in multiple organs. Because
the cell-of-origin of this tumor type is typi-
cally a pluripotent cell, these studies indi-
cate that the in vivo milieu is perfectly
amenable to nuclear reprogramming.
Indeed, ex vivo culture of cells derived
from these teratomas or circulating cells
of induced mice yields iPSCs in the
absence of further OKSM induction.
Abad and colleagues additionally demon-
strate that cells reprogrammed in thissetting acquired a more primitive, totipo-
tent state than in-vitro-derived iPSCs.
However, it remains to be determined
how iPSC potency can be so dramatically
affected in these distinct experimental
settings.
While these discoveries are highly sig-
nificant for the iPSC field, of potentially
greater interest are the unexpected in-
sights gained into theassociationbetween
nuclear reprogramming and cellular trans-
formation (Figure 1). A prominent acute ef-
fect of OKSM induction in both studies
was the formation of dysplastic lesions in
multiple tissues, potentially representing
early reprogrammingstepsen route toplu-
ripotency. Asmight be expected given the
initial dependence of in vitro reprogram-
ming on continual expression of exoge-
nous OKSM factors, Ohnishi et al. found
that tissue dysplasia was most often
reversed upon doxycycline withdrawal at
early time points after OKSM induction. A
more prolonged induction period resulted
in formation of tumors in multiple tissues
consisting of undifferentiated dysplastic
cells, which were distinct from teratomas.Strikingly, these tumors were resistant
to doxycycline withdrawal andweremain-
tained independently of transgenic OKSM
expression. The kidney seemed particu-
larly disposed to developing these tumors
and was a focus of study by the authors.
Critically, several lines of evidence indi-
cated that these tumors were derived
from kidney tubule cells that had partially
reprogrammed toward a pluripotent state
(partially reprogrammed transformed
cells; PRTCs). Transcriptional profiling
confirmed that PRTCs had lost tubule-
cell identity and adopted elements of an
embryonic stem cell (ESC) gene-expres-
sion program. Indeed, iPSCs could be
rapidly generated in vitro from tumor
cells upon further OKSM induction.
Further, modification of the reprogram-
ming cassette to omit specific OKSM fac-
tors demonstrated that the presence of
Oct3/4, considered the most critical re-
programming component (Takahashi and
Yamanaka, 2006), was essential for tumor
resistance to doxycycline removal. When
comparing gene expression between
PRTCs and ESCs, key differences were14, March 6, 2014 ª2014 Elsevier Inc. 269
Figure 1. Tumorigenesis in the Context of In Vivo Reprogramming
The reprogramming of somatic cells in vivo generates teratomas and iPSCs
upon long-term exposure to an OKSM transgene as shown by Ohnishi et al.
Short-term induction results in reversible tissue dysplasia. On the other
hand, longer OKSM expression gives rise to PRTCs. The expression of
Oct3/4 during reprogramming is essential for PRTC formation. These cells,
which resemble a progenitor state, are capable of forming tumors resistant
to OKSM withdrawal. Upon reactivation of OKSM, PRTCs reprogram into
iPSCs. Whether PRTCs are bona fide intermediates of the ‘‘normal’’ in vitro
and in vivo reprogramming pathways or are part of a parallel pathway remains
unclear.
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particular, genesnormally tar-
geted for polycomb-depen-
dent repression in ESCs
remained active in PRTCs.
Among these polycomb tar-
gets were kidney progenitor
genes such as Lgr5 and
Six2, which were specifically
activated in PRTCs.
Tumorigenesis is generally
driven by an accumulation of
genetic lesions; however by
exonic sequencing and array
CGH, the authors did not
find mutations or chromo-
somal alterations in the tu-
mors. Indeed, tumor-derived
iPSCs could successfully
contribute to chimeric mice
and normal kidney develop-
ment, indicating the absence
of permanent genetic aberra-
tions. Rather, gene methyl-
ation in tumor cells was
significantly perturbed and
genomic imprints were un-stable, strongly suggesting that PRTC
development was driven purely by
epigenetic mechanisms. Interestingly,
alterations in the methylation of im-
printed genes are associated with the
pathogenesis of Wilms’ tumors, a type of
pediatric kidney cancer (Steenman et al.,
1994).
On the surface, the study of Ohnishi
et al. provides a clear link between nu-
clear reprogramming and transformation;
however, when looked at in depth, it may
outline a new model of tumorigenesis.
Many previous reports have linked indi-
vidual iPSC reprogramming factors to
tumor development to varying extents
(Suva` et al., 2013). However, the novelty
in this study lies with the demonstration
that a transient combined induction of
OKSM is sufficient to induce a stably
transformed state through epigenetic
rather than genetic mechanisms, at least
in some cell types. While perturbed gene
methylation appears to underlie PRTC
development, the details of the epige-
netic landscape imparted by OKSM
expression in order to confer a perma-
nently transformed state await full char-
acterization. In particular, which are the
key genes that must be reactivated or
silenced for this induced transformation?
Further, although the induced kidney270 Cell Stem Cell 14, March 6, 2014 ª2014tumors bear a considerable resemblance
to human disease, in what pathological
settings would a similar mechanism of
tumor initiation operate?
It has been well documented that
essentially all cell types can be reprog-
rammed in vitro (Stadtfeld and Hoched-
linger, 2010). As these two groups have
shown, teratomas can be found in multi-
ple organs, indicating that many cell
types are also amenable to reprogram-
ming in vivo. However, it appears that
PRTCs are preferentially generated in
certain organs, which may indicate that
the original epigenetic landscape and/or
transcriptional network not only plays a
key role in the function of derived iPSCs
(Kim et al., 2010; Polo et al., 2010) but
also is of great relevance to induction of
cellular transformation. The fact that the
kidney tumors reported by Ohnishi et al.
expressed markers of renal progenitors,
such as Lgr5, is an important observation
that prompts many questions. Is tumor
induction related to having a primitive
progenitor cell in an adult environment,
in a similar manner to how transplanted
ESCs give rise to teratomas in adults
but not in blastocysts? Is this transforma-
tion related to a more immature epige-
netic landscape, or does the environment
bias toward dedifferentiation into aElsevier Inc.progenitor state during in vivo
reprogramming? These inter-
esting concepts remain
largely unexplored. Moreover,
Lgr5 is not expressed in
iPSCs, and neither is it tran-
siently expressed during the
reprogramming of fibroblasts
(Polo et al., 2012) nor in vitro
generated partially reprog-
rammed cells (Sridharan
et al., 2009). Therefore, from
a reprogramming perspective,
it is unclear whether Lgr5+
cells are an intermediate state
during the reprogramming of
renal cells, which would indi-
cate a reversion of the
developmental pathway.
Alternatively, it could repre-
sent a parallel pathway that
these cells may follow during
reprogramming or revert
back to once doxycycline is
removed.
Once more, the reprogram-
ming technology proves itsimmense value to the study of different
diseases. The development of xenotrans-
plantation reprogramming models may
enhance our understanding of human
cancer initiation and progression and the
role of epigenetic mechanisms in these
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http://dx.doi.org/10.1016/j.stem.2014.02.011Intestinal homeostasis is dependent upon stem cells that reside in the intestinal crypt, although the identity
and dynamics of this population are unclear. Ritsma et al. (2014) recently reported temporal live imaging of
mouse intestinal stem cells and their progeny, providing insights into spatial dynamics underlying stem cell
behavior.The intestine is characterized by rapid
turnover of mature cells. Recent studies
have suggested that at least two pheno-
typically distinct stem cell populations
contribute to homeostasis and mainte-
nance of the intestinal epithelium: (1) crypt
base columnar cells (CBCs) located
around the base of the intestinal crypt
and (2) quiescent stem cells located at
about position +4 from the base of the
crypt. As stem cells divide, their progeny
are displaced from the crypt toward the
villus (Figure 1), and this process is asso-
ciated with transit amplification, fate
commitment, and differentiation into
multiple specialized cell types. A major
unanswered question in intestinal
stem cell biology is whether individual
crypt stem cells share identical pro-
perties and potential, which might be
obscured by the display of discrete
behaviors, thus leading to their classifica-
tion as distinct stem cell subpopula-
tions, or whether there is a hierarchical
relationship between them that might
delimit their functionality.
To address some of these questions,
Ritsma and colleagues (Ritsma et al.,
2014) took on the challenge of followingintestinal stem cells and their progeny
directly in the living mouse over extended
periods of time. They first addressed the
significant technical challenges associ-
ated with such an approach, including
placement of a viewing window in soft
tissue to allow repeated sessions of
live imaging without losing track of cell
position over time, and preventing the an-
imals from dislodging the imaging win-
dow. Although imaging windows have
been described previously for intravital
microscopy, the anatomical disposition
of the intestine required surgical
implantation of a modified abdominal
imaging window (Ritsma et al., 2013).
Remarkably, by using stereotyped pat-
terns of genetically labeled cells in the
crypts, as well as unique landmarks of
the adjacent vasculature, it was possible
to repeatedly home into previously
imaged crypts at regular time intervals.
Similar intravital imaging was done
for stem cell populations within hair
follicles in the mouse ear (Rompolas
et al., 2012).
Clonal cell tracking in the crypt
is achievable using the multicolor
R26RConfetti floxed mouse that can beconditionally activated with a tamoxifen-
inducible CreERT2 recombinase (Snippert
et al., 2010). Ritsma and colleagues used
Lgr5EGFP-IRES-CreERT2 mice to induce
recombination specifically in undifferenti-
ated crypt stem cells, generating CBCs
labeled with one of four different fluores-
cent reporters. Using this system, the
authors tracked 80 CBCs at timed inter-
vals over a 5 day period. This data set
revealed a wide range of cell behaviors
including variance in clone size and
displacement of cells from the crypt
compartment. Notably, only 1 of 28
clones examined contained a single cell
after 2 days. The authors suggest that
these might be fated to the lineage-
committed quiescent +4 position and
did not pursue this class of clone further.
Clones were then classified, relative to
their position to the base of the crypt,
as either central (from row 0 to +2) or
border (from +3 to +4; Figure 1). Interest-
ingly, clones initiating from central cells
tended to be larger than those origi-
nating at the border, suggesting that
daughters of central cells might displace
border cells out of the niche into the
transit-amplifying population.14, March 6, 2014 ª2014 Elsevier Inc. 271
